You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 5, August 1, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Lung Cancer
 •Pulmonary Diseases
 •Pulmonary Diseases, Other
 •Radiologic Imaging
 •Statistics and Research Methods
 •Angiology
 •Computed Tomography
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Computed Tomography Screening for Lung Cancer

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Bach and colleagues1 statistically modeled whether earlier detection of lung cancer with low-dose helical CT and subsequent longer survival after diagnosis necessarily translates into a lower lung cancer mortality rate. According to the authors' predictive model,2 the number of expected lung cancer deaths among 3 single-group cohort studies was no lower than would have been expected without screening. The authors correctly caution prudence about widespread dissemination of CT screening until the results of large-scale randomized controlled trials—including the National Lung Screening Trial (NLST) and several European trials—are completed; the earliest results may be available in 2009. However, the authors raise concerns that the NLST may not be adequately designed to observe a reduction in lung cancer mortality, should one exist, given the number of annual screens in the NLST and the planned duration of follow-up. We would like to address these concerns.

The NLST enrolled 53 464 . . . [Full Text of this Article]

Christine D. Berg, MD
bergc@mail.nih.gov
National Cancer Institute
Bethesda, Maryland

Denise R. Aberle, MD
David Geffen School of Medicine at UCLA
Los Angeles, California



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Computed Tomography Screening for Lung Cancer
Ambarish Gopal and Matthew J. Budoff
JAMA. 2007;298(5):513.
EXTRACT | FULL TEXT  

Computed Tomography Screening for Lung Cancer
Lorenzo Spaggiari, Giulia Veronesi, Massimo Bellomi, and Patrick Maisonneuve
JAMA. 2007;298(5):514.
EXTRACT | FULL TEXT  

Computed Tomography Screening for Lung Cancer
Claudia I. Henschke, David Yankelevitz, James P. Smith, and Olli S. Miettinen
JAMA. 2007;298(5):514-515.
EXTRACT | FULL TEXT  

Computed Tomography Screening for Lung Cancer—Reply
Peter B. Bach, James R. Jett, Ugo Pastorino, Melvyn S. Tockman, Stephen J. Swensen, and Colin B. Begg
JAMA. 2007;298(5):515-516.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Computed Tomography Screening and Lung Cancer Outcomes
Peter B. Bach, James R. Jett, Ugo Pastorino, Melvyn S. Tockman, Stephen J. Swensen, and Colin B. Begg
JAMA. 2007;297(9):953-961.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.